Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotrophic Keratopathy Stage 1”

4 trials

Showing 4 of 4 results

Post-approval studies (Phase 4)Looking for participantsNCT07502378
What this trial is testing

Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency

Who this might be right for
Ocular Surface DiseaseNeurotrophic Keratopathy Stage 1
University of South Florida 50
Testing effectiveness (Phase 2)Looking for participantsNCT06999733
What this trial is testing

A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis

Who this might be right for
Neurotrophic Keratitis
Krystal Biotech, Inc. 60
Post-approval studies (Phase 4)Study completedNCT04485546
What this trial is testing

Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis

Who this might be right for
Neurotrophic Keratitis
Dompé Farmaceutici S.p.A 37
Not applicableStudy completedNCT05552261
What this trial is testing

DEFENDO Long Term Follow-up Study in Stage 1 NK Patients

Who this might be right for
Neurotrophic Keratitis
Dompé Farmaceutici S.p.A 24

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation